Literature DB >> 33223958

Corrigendum to "Interleukin-9 Deletion Relieves Vascular Dysfunction and Decreases Blood Pressure via the STAT3 Pathway in Angiotensin II-Treated Mice".

Yunzhao Yang1, Shaoqun Tang1, Chunchun Zhai1, Xin Zeng1, Qingjian Liu1, Cheng Xu1, Hexiang Chen1.   

Abstract

[This corrects the article DOI: 10.1155/2020/5741047.].
Copyright © 2020 Yunzhao Yang et al.

Entities:  

Year:  2020        PMID: 33223958      PMCID: PMC7669330          DOI: 10.1155/2020/8537832

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


In the article titled “Interleukin-9 Deletion Relieves Vascular Dysfunction and Decreases Blood Pressure via the STAT3 Pathway in Angiotensin II-Treated Mice” [1], the authors apologize that a blot of P-STAT3 which did not belong to this study was mistakenly used in (Figure 6(c)). The statistical results of P-STAT3 protein expression were correct, and the corrected (Figure 6(c)) is shown below.
Figure 1

Effects of S31-201 on blood pressure, inflammation, and phenotypic transformation of smooth muscle. (a, b) Blood pressure was determined using the tail-cuff method and the Millar Pressure Volume System; N = 10 in each group. (c) The STAT3 phosphorylation in each group was measured. (d) The vascular function for the four groups was detected. (e) Serum cytokine levels were measured using ELISA kits. (f) Aortic mRNA expression of cytokines was analyzed by RT-PCR. N = 5 in each group; ∗p < 0.05 vs. the IL-9-/- Ang II+DMSO group.

  1 in total

1.  Interleukin-9 Deletion Relieves Vascular Dysfunction and Decreases Blood Pressure via the STAT3 Pathway in Angiotensin II-Treated Mice.

Authors:  Yunzhao Yang; Shaoqun Tang; Chunchun Zhai; Xin Zeng; Qingjian Liu; Cheng Xu; Hexiang Chen
Journal:  Mediators Inflamm       Date:  2020-02-14       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.